Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Hannah N Imlay, Daniel R Kaul

Abstract

Until recently, available drugs for cytomegalovirus (CMV) prevention and treatment in transplant patients included (val)ganciclovir, foscarnet, and cidofovir. Use of these drugs is limited by toxicity and the development of resistance. The 2017 approval of letermovir for prevention of CMV after stem cell transplant marked the first approval of an anti-CMV agent since 2003. The role of letermovir in treatment of established CMV infection or disease remains largely unstudied, although early reports suggest that a low barrier to resistance will likely limit efficacy as primary therapy for patients with refractory or resistant disease. The investigational agent maribavir has shown promise as preemptive treatment; in patients with refractory or resistant disease the emergence of resistance while on treatment has been observed and ongoing studies will define efficacy in this population. Both agents have unique mechanisms of action limiting cross resistance, and neither exhibit myelotoxicity or nephrotoxicity.

References

Feb 7, 2002·Blood·Pierre ReusserUNKNOWN Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Apr 4, 2002·Blood·Per LjungmanUNKNOWN Valacyclovir International Bone Marrow Transplant Study Group
Sep 12, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W Lawrence DrewSunwen Chou
Aug 14, 2008·The Annals of Pharmacotherapy·Jennifer TrofeRoy D Bloom
Aug 12, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M D PescovitzS A Villano
Oct 30, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Susanne StoelbenKlemens Budde
Jun 27, 2015·The Journal of Infectious Diseases·Peter LischkaHolger Zimmermann
Oct 3, 2017·Clinical Pharmacology in Drug Development·Dirk KropeitHolger Zimmermann
Dec 7, 2017·The New England Journal of Medicine·Francisco M MartyCyrus Badshah
Oct 8, 2018·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Francisco M MartyUNKNOWN SUPPRESS Trial Clinical Study Group
Oct 18, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Genovefa A PapanicolaouStephen Villano
Sep 19, 2019·The New England Journal of Medicine·Johan MaertensStephen Villano
Dec 5, 2019·The Journal of Antimicrobial Chemotherapy·Arianne DuongCatherine Liu
Dec 29, 2019·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Francisco M MartyCyrus S Badshah
Feb 9, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christine RobinCatherine Cordonnier
Mar 7, 2020·The Journal of Infectious Diseases·Ghady HaidarNina Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved